Document is current
Any future updates will be listed below
-
Authors
Hwang, Eugene I. https://orcid.org/0000-0002-3923-1135
Sayour, Elias J.
Flores, Catherine T.
Grant, Gerald
Wechsler-Reya, Robert https://orcid.org/0000-0002-7463-8352
Hoang-Minh, Lan B.
Kieran, Mark W.
Salcido, Joanne
Prins, Robert M. https://orcid.org/0000-0002-6282-6583
Figg, John W.
Platten, Michael https://orcid.org/0000-0002-4746-887X
Candelario, Kate M. https://orcid.org/0000-0003-2290-2657
Hale, Paul G.
Blatt, Jason E. https://orcid.org/0000-0001-6892-7724
Governale, Lance S.
Okada, Hideho
Mitchell, Duane A.
Pollack, Ian F.
- License Information
-
More Information
Article History
Received: 8 October 2020
Accepted: 24 November 2021
First Online: 20 January 2022
Competing interests
: All authors declare no conflict of interest, with the following exceptions: M.W.K. is an employee and stock holder of Day One Biopharmaceuticals and M.P. holds patents on histone anti-cancer vaccines (US20180155403A1) and on tryptophan metabolism in cancer immunotherapy (EP2753315B1 and EP3464248A1).
